
Ellis Pharma Private Limited
About Ellis Pharma Private Limited
Data last updated:
Ellis Pharma Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 June 1996 and has been in existence for over 30 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ1996PTC029850. Its GSTIN is 24AAACE4803A1ZH (Gujarat).
The company has an authorised share capital of ₹35 Lakh and a paid-up capital of ₹34 Lakh. It is led by directors including Jamsa Ahmed Soaib and Samim Surati.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 4 GIDC Behrampurakhodiyarnagar, Ahmedabad, Gujarat, India – 380028.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.27 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹80.19 Lakh (net margin 24.6%) and EBITDA of ₹92.28 Lakh (EBITDA margin 28.3%). Revenue has grown at a compounded annual rate (CAGR) of 30% over three years and 15% over five years.
The company has about 7 employees on its provident fund (EPFO) records.
As per MCA filings, the company has satisfied charges of ₹62 Lakh on record. Court records list 3 cases involving the company, including 3 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Ellis Pharma Private Limited's registered office is in Ahmedabad, Gujarat. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No 4 GIDC Behrampurakhodiyarnagar, Ahmedabad, Gujarat, India – 380028
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Ellis Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ellis Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Ellis Pharma Private Limited, buy the company report.
Financials of Ellis Pharma Private Limited
FY 2025 filings availableEllis Pharma Private Limited reported revenue of ₹3.27 Cr (up 152% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 15% over five years, including 152% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹92.28 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹80.19 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 28.3% | ||||
| Net Profit Margin | 24.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ellis Pharma Private Limited, buy the company report.
Board of directors of Ellis Pharma Private Limited
Ellis Pharma has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jamsa Ahmed Soaib | Director | 11 Sep 2018 | 8 Years 2 Months | Current |
| Samim Surati | Additional Director | 04 Apr 2025 | 1 Years 7 Months | Current |
| Naznin Soaib Jamsa | Additional Director | 28 Mar 2025 | 1 Years 7 Months | Current |
Auditor
Ellis Pharma Private Limited is audited by NALIN K THAKKAR & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| NALIN K THAKKAR & CO | FY 2019 | 116546W |
Shareholding
The shareholding of Ellis Pharma Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Ellis Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 19 Apr 2004 | 90110725 | Small Industries Development Bank of India | ₹50 Lakh | Satisfied | |
| 27 Dec 2002 | 90110505 | Union Bank of India | ₹12 Lakh | Satisfied |
To see the full charge records of Ellis Pharma Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
Ellis Pharma Private Limited has 3 court cases on record: 3 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 3 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Nagpur, Maharashtra | Civil suit | Filed against the company | Disposed |
| District court, Nagpur, Maharashtra | Court case (R.C.C.) | Filed against the company by State of Maharashtra F. D. | Disposed |
| District court, Ahmedabad, Gujarat | Court case (CS CCC) | Filed against the company by Smithkline Beecham PLC. and 2 others | Disposed |
To see the full case history of Ellis Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ellis Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ellis Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAACE4803A1ZH | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Ellis Pharma Private Limited, buy the company report.
Recent activity
Ellis Pharma Private Limited has 9 board changes on record since 2011: 4 appointments and 5 cessations. The latest: Samim Surati was appointed as Additional Director on 04 Apr 2025.
6 earlier events are in the company report.
Frequently asked questions
Ellis Pharma is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 June 1996 (30+ years old) and is registered under CIN U24230GJ1996PTC029850.
Ellis Pharma has 3 current directors:
- Jamsa Ahmed Soaib - Director
- Samim Surati - Additional Director
- Naznin Soaib Jamsa - Additional Director
The latest financial statements of Ellis Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Ellis Pharma is 24AAACE4803A1ZH, registered in Gujarat.
The CIN (Corporate Identification Number) of Ellis Pharma is U24230GJ1996PTC029850. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ellis Pharma has 3 court cases on record: 3 filed against it.
Ellis Pharma was incorporated on 07 June 1996, making it 30+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Samim Surati was appointed as Additional Director on 04 Apr 2025. Naznin Soaib Jamsa was appointed as Additional Director on 28 Mar 2025. Mazhar Jaferhusein Mansuri ceased to be Additional Director on 29 Sep 2024. Ellis Pharma has 9 board changes on record in total.
The registered office of Ellis Pharma is at Plot No 4 GIDC Behrampurakhodiyarnagar, Ahmedabad, Gujarat, India – 380028.
Ellis Pharma operates in the pharma industry, in the drug formulation and development segment.

